Medium
NA
$24.98
Management of multi-drug resistant infections caused by Enterobactericiae, Acinetobacter, and Pseudomonas (on a case by case basis)
Severe infections caused by multidrug-resistant gram-negative organisms when other antimicrobial options are limited.
Phlebitis at infusion site
Neurotoxicity
Nephrotoxicity in up to 20% of patients
Inhaled form: bronchospasm
IV Administration
Dilute in 50-100 mL D5W or NS and administer over 30 min.
EH Prescribing Restrictions
None
Pharmacist review of therapy
Community IV Formulary (Metro Area)
YES
Pregnancy category: C
Average serum half life: 2-3 hr
Route of Elimination: Primarily urine